Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer

NCT00525096 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

157

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: placebo
DRUG: Celecoxib
DRUG: Exemestane

Sponsor

ARCAGY/ GINECO GROUP